Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.reuters.com/business/healthcare-pharmaceuticals/lundbeck-drug-candidate-shows-promise-cushings-disease-trial-2026-06-14/ · 6/14/2026+0.80
https://www.reuters.com/business/healthcare-pharmaceuticals/lundbecks-experimental-drug-cuts-migraine-days-mid-stage-trial-2026-06-04/ · 6/4/2026+0.80
https://www.zacks.com/stock/news/2793522/alks-raises-its-offer-to-buy-avadel-in-response-to-lundbeck-s-proposal?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2793522 · 11/20/2025-0.40
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
